RXWell to Decrease Post-Operative Opioid Use in Total Knee or Hip Arthroplasty
NCT05658796
This study is recruiting at 3 US sites in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
It is envisioned that multipronged benefits from this pilot work for the UPMC ISD and its members. It is expected the RxWell platform to provide the following benefits: expansion of the use of RxWell to all UPMC ISD members providing peri-operative mood management with advantage of improved peri-operative outcomes, improving saving for the UPMC ISD by hastening the recovery and decreased resource utilization, and addition to the high-value care of UPMC with this holistic approach to patient perioperative care
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Mood Disorders
- Anxiety
- Depressive Symptoms
- Depression
- Anxiety Disorders
- Anxiety Depression
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 18 to 100 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- University of Pittsburgh
- Last updated on ClinicalTrials.gov
- June 3, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Pennsylvania · 3
- UPMC East · Monroeville, PA
- UPMC Passavant · Pittsburgh, PA
- UPMC Shadyside · Pittsburgh, PA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.